Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas at Austin
With
Prolacta Bioscience
A single patient observational study to evaluate growth velocity and clinical outcomes of an infant status post cardiac surgery who has failed to grow well and demonstrated intolerance to cow milk-based and elemental formulas and fortifiers on a 100% human milk diet. Human milk is defined as expressed human milk or donor milk and its derivatives, human milk-based fortifier and human milk caloric fortifier.
The study hypothesis is that this infant if fed an exclusive human milk diet will have improved growth in part due to data greater tolerability of the diet.
It is estimated that the study will require 90 days to complete. Growth in safety observations will be collected only during the time the patient is receiving the diet.
The primary objective is to evaluate growth velocity (weight velocity \[g/kg/day\] of a single infant receiving a 100% human milk diet including a human milk based human milk fortifier formulated for term infants who are fluid restricted due to surgically correctable congenital conditions. This will be compared to the infant's growth velocity prior to the initiation of said diet.
Age
0–1
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Complex congenital heart disease in presence of poor linear and head circumference growth and unable to tolerate cow's milk protein
You may not be if
n/a
Clareo Health | Outpatient Exclusive Human Milk Diet for Single Infant With Complex Congenital Heart Disease